Key facts
- This page summarizes Mark Eisner's Form 3 filing for Zura Bio Ltd (ZURA).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Feb 2026, 21:12.
Mark Eisner - 21 Feb 2026 Form 3 Insider Report for Zura Bio Ltd (ZURA)
- Reporting relationship
- Director
- Issuer ticker
- ZURA
- Reported as of
- 21 Feb 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 24 Feb 2026, 21:12:41 UTC
- Prior SEC filing
- 17 Jul 2025
- Next SEC filing
- 24 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kim Davis, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Mark Eisner filed Form 3 for Zura Bio Ltd (ZURA) on 24 Feb 2026.
Change
- Previous filing in this sequence was filed on 17 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001834161
Primary reporting owner
Eisner Mark
- Relationship
- Director
- Address
- C/O ZURA BIO LIMITED, 1489 W. WARM SPRINGS RD. #110, HENDERSON
- Signature
- /s/ Kim Davis, Attorney-in-Fact
- Signature date
- 24 Feb 2026
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.